Evidence map›Paper›PMID 34957725›Full record

ArticleRadiology and oncology2021

Diagnostic performance of apparent diffusion coefficient values for the differentiation of intrahepatic cholangiocarcinoma from gastrointestinal adenocarcinoma liver metastases.

Temel Fatih Yilmaz, Mehmet Ali Gultekin, Hacı Mehmet Turk, Mehmet Besiroglu, Dilek Hacer Cesme, Melih Simsek, Alpay Alkan, Huseyin Toprak

Abstract read
In one paragraph

Article in Radiology and oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Temel Fatih YilmazDepartments of Radiology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
Mehmet Ali GultekinDepartments of Radiology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
Hacı Mehmet TurkDepartments of Medical Oncology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
Mehmet BesirogluDepartments of Medical Oncology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
Dilek Hacer CesmeDepartments of Radiology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
Melih SimsekDepartments of Medical Oncology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
Alpay AlkanDepartments of Radiology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
Huseyin ToprakDepartments of Radiology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe aimed to investigate whether there is a difference between intrahepatic cholangiocarcinoma (IHCC) and liver metastases of gastrointestinal system (GIS) adenocarcinoma in terms of apparent diffusion coefficient (ADC) values. PATIENTS AND

methodsFrom January 2018 to January 2020, we retrospectively examined 64 consecutive patients with liver metastases due to gastrointestinal system adenocarcinomas and 13 consecutive IHCC in our hospital's medical records. After exclusions, fifty-three patients with 53 liver metastases and 10 IHCC were included in our study. We divided the patients into two groups as IHCC and liver metastases of GIS adenocarcinoma. For mean apparent diffusion coefficient (ADC

resultsThe mean age of IHCC group was 62.50 ± 13.49 and mean age of metastases group was 61.15 ± 9.18. ADC

conclusionsThe present study results suggest that ADC values have a potential role for differentiation between IHCC and GIS adenocarcinoma liver metastases which may be valuable for patient management.

Indexed as

Bile Duct NeoplasmsCholangiocarcinomaLiver NeoplasmsBile Ducts, IntrahepaticHumansRetrospective Studiesapparent diffusion coefficientcholangiocarcinomadiffusion weighted imagegatrointestinal systemliver metastasesMRI

Identifiers

PMID34957725
PMCPMC8884850

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.